PROMETHERA BIOSCIENCES

PrometheraÂ® Biosciences is a biopharmaceutical company, spin-off of the UniversitÃ© Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. PrometheraÂ® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers. PrometheraÂ® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):

#People #Financial #Event #Website #More

PROMETHERA BIOSCIENCES

Social Links:

Industry:

Biotechnology Pharmaceutical Therapeutics

Founded:

2009-01-01

Address:

Mont-saint-guibert, Brabant Wallon, Belgium

Country:

Belgium

Website Url:

http://www.promethera.com

Total Employee:

101+

Status:

Active

Contact:

Email Addresses:

[email protected]

Total Funding:

149.1 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Office 365 Mail Vimeo GlobalSign Domain Verification Vimeo CDN DocuSign Symantec.cloud Exclaimer Equinix

Current Advisors List

etienne-sokal_image

Etienne Sokal Chairman of the Board of Directors @ Promethera Biosciences
Board_member

Current Employees Featured

bertrand-lellouche_image

Bertrand Lellouche
Bertrand Lellouche GROUP CFO @ Promethera Biosciences
GROUP CFO
2018-10-01

william-macias_image

William Macias
William Macias Chief Medical Officer ad interim @ Promethera Biosciences
Chief Medical Officer ad interim
2020-03-01

john-tchelingerian_image

John Tchelingerian
John Tchelingerian CEO & President @ Promethera Biosciences
CEO & President
2016-06-01

not_available_image

Claude Dedry
Claude Dedry COO @ Promethera Biosciences
COO

Founder

etienne-sokal_image

Etienne Sokal

Acquisitions List

Date	Company	Article	Price
2018-04-10	Baliopharm	Baliopharm acquired by Promethera Biosciences	N/A

Investors List

pegasus-tech-ventures_image

Pegasus Tech Ventures

Pegasus Tech Ventures investment in Series D - Promethera Biosciences

sony-innovation-fund_image

Sony Innovation Fund

Sony Innovation Fund investment in Series D - Promethera Biosciences

itochu-technology-ventures_image

ITOCHU Technology Ventures

ITOCHU Technology Ventures investment in Series D - Promethera Biosciences

sansei-capital-investment_image

Sansei Capital Investment

Sansei Capital Investment investment in Series D - Promethera Biosciences

shibuya-kogyo_image

Shibuya Kogyo

Shibuya Kogyo investment in Convertible Note - Promethera Biosciences

shinsei-corporate-investment-limited_image

Shinsei Corporate Investment

Shinsei Corporate Investment investment in Convertible Note - Promethera Biosciences

boehringer-ingelheim-venture-fund_image

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund investment in Series C - Promethera Biosciences

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series C - Promethera Biosciences

fund_image

Fund+

Fund+ investment in Series C - Promethera Biosciences

mitsubishi-ufj-capital_image

Mitsubishi UFJ Capital

Mitsubishi UFJ Capital investment in Series C - Promethera Biosciences

Key Employee Changes

Date	New article
2019-12-11	Prometheus Bio Taps Thierry Dervieux as Chief Development Officer

Official Site Inspections

http://www.promethera.com

Host Informations
Whois Informations

Loading ...

More informations about "Promethera Biosciences" on Search Engine